Investor Presentaiton

Strong Customer Focus Drives Market Share Gains SUN 200 150 100 50 50 Therapy focused marketing 9,000+ sales representatives Covering over 600,000* doctors Strong increase in market share Sun pharma market share has consistently increased from 2.1% in 2000 to 4.8% in 2014 Including Ranbaxy, current market share is 8.1% (IMS Data for Sept'15) 8.1% * Does not exclude overlaps 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 Source: IMS -Cipla Ranbaxy -Sun -Cadila Lupin DRL Torrent Wockhardt -Ipca © Sun Pharmaceutical Industries Limited. All Rights Reserved. 24 PHARMA

View entire presentation